Cargando…

A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1

Recent studies indicate that soluble oligomers drive pathogenesis in several neurodegenerative proteinopathies, including Alzheimer and Parkinson disease. Curiously, the same conformational antibody recognizes different disease-related oligomers, despite the variations in clinical presentation and b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasagna-Reeves, Cristian A, Rousseaux, Maxime WC, Guerrero-Muñoz, Marcos J, Park, Jeehye, Jafar-Nejad, Paymaan, Richman, Ronald, Lu, Nan, Sengupta, Urmi, Litvinchuk, Alexandra, Orr, Harry T, Kayed, Rakez, Zoghbi, Huda Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462648/ https://www.ncbi.nlm.nih.gov/pubmed/25988806 http://dx.doi.org/10.7554/eLife.07558

Ejemplares similares

Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2015)

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2011)

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
por: Sengupta, Urmi, et al.
Publicado: (2016)

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
por: Lasagna-Reeves, Cristian A., et al.
Publicado: (2012)

dAtaxin-2 Mediates Expanded Ataxin-1-Induced Neurodegeneration in a Drosophila Model of SCA1
por: Al-Ramahi, Ismael, et al.
Publicado: (2007)

Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies
por: Moore, Kenya, et al.
Publicado: (2023)

Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
por: Perroud, Bertrand, et al.
Publicado: (2013)

α-Synuclein Oligomers Induce a Unique Toxic Tau Strain
por: Castillo-Carranza, Diana L., et al.
Publicado: (2018)

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
por: Rousseaux, Maxime WC, et al.
Publicado: (2016)

Characterization of tau oligomeric seeds in progressive supranuclear palsy
por: Gerson, Julia E, et al.
Publicado: (2014)

Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration
por: Montalbano, Mauro, et al.
Publicado: (2019)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
por: Gerson, Julia E., et al.
Publicado: (2018)

Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
por: Bittar, Alice, et al.
Publicado: (2018)

Quantification and targeting of elusive neurotoxic amyloid oligomers
por: Bhatt, Nemil, et al.
Publicado: (2022)

Association of Skin with the Pathogenesis and Treatment of Neurodegenerative Amyloidosis
por: Clos, Audra L., et al.
Publicado: (2012)

Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementia
por: Gaikwad, Sagar, et al.
Publicado: (2021)

The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2014)

Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease
por: Puangmalai, Nicha, et al.
Publicado: (2022)

Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies
por: Puangmalai, Nicha, et al.
Publicado: (2020)

14-3-3 Binding to Ataxin-1(ATXN1) Regulates Its Dephosphorylation at Ser-776 and Transport to the Nucleus
por: Lai, Shaojuan, et al.
Publicado: (2011)

Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases
por: Nilson, Ashley N., et al.
Publicado: (2016)

Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
por: Montalbano, Mauro, et al.
Publicado: (2022)

Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis
por: Crespo-Barreto, Juan, et al.
Publicado: (2010)

Motor neuron degeneration correlates with respiratory dysfunction in SCA1
por: Orengo, James P., et al.
Publicado: (2018)

Ataxin-3, DNA Damage Repair, and SCA3 Cerebellar Degeneration: On the Path to Parsimony?
por: Ward, Jacqueline M., et al.
Publicado: (2015)

Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
por: Fernandez‐Perez, Eduardo J., et al.
Publicado: (2021)

Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies
por: Castillo-Carranza, Diana L, et al.
Publicado: (2017)

Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
por: Sengupta, Urmi, et al.
Publicado: (2020)

Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
por: Jung, Joonil, et al.
Publicado: (2009)

Therapeutic reduction of ataxin 2 extends lifespan and reduces pathology in TDP-43 mice
por: Becker, Lindsay A., et al.
Publicado: (2017)

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
por: Sengupta, Urmi, et al.
Publicado: (2018)

Design of RNAi Hairpins for Mutation-Specific Silencing of Ataxin-7 and Correction of a SCA7 Phenotype
por: Scholefield, Janine, et al.
Publicado: (2009)

Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives
por: Lo Cascio, Filippa, et al.
Publicado: (2019)

Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure
por: Sokolov, Yuri, et al.
Publicado: (2006)

Ataxin-2 Regulates RGS8 Translation in a New BAC-SCA2 Transgenic Mouse Model
por: Dansithong, Warunee, et al.
Publicado: (2015)

SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models
por: Marinello, Martina, et al.
Publicado: (2019)

Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
por: Hauser, Stefan, et al.
Publicado: (2021)

Reduction of mutant ATXN1 rescues premature death in a conditional SCA1 mouse model
por: Orengo, James P., et al.
Publicado: (2022)

Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1
por: Lee, Won-Seok, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_50q7pi5uf3smq45b0jqtrom4gq